🌱 KidneyEnergy.com

← brief for 2026-10-16 · Slowing decline

Effects of SGLT-2 inhibitors on thyroid-stimulating hormone and systemic immune-inflammation index in type 2 diabetes: a retrospective study.

Article C Peer reviewed Observational

Key takeaways

This study looked at people with type 2 diabetes who took a common kidney-protecting drug for at least six months. It found a link between taking this drug and changes in the body's immune balance. This is an observational study, so it shows a link, not proof of cause. The drug is known to help kidneys, but this specific finding needs more testing.

Who did this work

Bayram SM · Demirci H · Üçgül E · Canlar Ş · Cinel M · Menekşe B · Kuşabbi İA · Çakal E

Source

Article · PubMed, the drug frontier · 2026 Sep 11
https://pubmed.ncbi.nlm.nih.gov/42881387/